CyberMDX, a NYC- and Lyon, France-based healthcare cybersecurity provider, secured $20m in funding.
The round, which brought its fundraising total to $30m, was led by Sham (Relyens group), with participation from existing investors Pitango Venture Capital and Qure Ventures.
The company intends to use the funds to boost geographic expansion and go-to-market activities, to further expand its technology platform and research capabilities to assist hospital IT and Biomed teams in securing and managing all network connected devices.
Led by Amir Magner, CEO and co-founder, CyberMDX is a healthcare cybersecurity provider delivering visibility, threat prevention, and operational efficiency for medical devices, IoT, and clinical networks. The system identifies, categorizes, and protects connected medical devices, ensuring resiliency as well as patient safety and data privacy.
With CyberMDX’s continuous endpoint discovery & mapping, comprehensive risk assessment, AI-powered containment & response, and operational analytics, risks are mitigated and assets optimized.